Back to All States

Astellas Pharma US, Inc. | Company Profile, Marketing Contacts, Media Spend, Brands




Astellas Pharma US, Inc., headquartered in Deerfield, IL, is the American branch of the Japanese pharmaceutical company. Clinical development is centered at the Deerfield location. ** NOTE: As a privately held subsidiary of a publicly traded parent company, annual revenue and employee count are not readily available. Therefore, the revenue and employee figures presented below are those of the parent company. **

Main Telephone
(224) 205-8800
Primary Address
One Astellas Way
Northbrook, IL 60062
USA

Astellas Pharma US, Inc. Contacts

Contacts (5/93)
Name Title State
Bernhardt G. Z. Chief Medical Officer IL
Sample of Related Brands
***********
Email: *****@*******.***
Main Phone: (224) 205-8800
Direct Phone: *** **** ***   ext: ****
Assistant Name: ** **** ***
Assistant Phone: *** **** ***
Address: One Astellas Way

Northbrook, IL
60062
USA

Dale J. Chief Marketing Officer & Director, Quality Assurance IL
Mark R. President, U.S. Commercial IL
Charlotte K. Executive Vice President & Head - Medical Affairs IL
Linda F. Executive Vice President, General Counsel IL

Media Spend

Media Spend Summary
Media Spend Channel

Related Brands

Brand Media Spend
Adenocard *
Adenoscan *
AmBisome *
Prograf *
Protopic *

Agency Roster


Brand Agency Service From To
********* *** media buying & planning unknown present
********* ******* ***** ***** - ******* media buying & planning unknown present
********* *** media buying & planning unknown present
********* ******* ***** ***** - ******* media buying & planning unknown present
******** *** media buying & planning unknown present

See Winmo sales intelligence in action

WinmoEdge

Future Possibility: Astellas Pharmaceuticals taps new senior director of product, brand communications (Score 22)


As part of a larger communications team restructuring, pharmaceutical company Astellas has just appointed Colin McBean as senior director of US product and brand communications, effective April 30....